Table 1.
Gene | Cytogenetic location |
---|---|
ARX | Xp21.3 |
CDKL5 | Xp22.13 |
PAFAH1B1/LIS1 | 17p13.3 |
DCX | Xq23 |
TUBA1A | 12q13.12 |
STXBP1 | 9q34.11 |
KCNQ2 | 20q13.33 |
SPTAN | 9q34.11 |
MAGI2 | 7q21.11 |
GRIN2A | 16p13.2 |
FOXG1 | 14q12 |
NSD1 | 5q35.3 |
NEDD4 | 15q21.3 |
CALN1 | 7q11.22 |
WDR45 | Xp11.23 |
SLC1A4 | 2p14 |
RARS2 | 6q15 |
UBA5 | 3q22.1 |
IARS2 | 1q41 |
PHACTR1 | 6p24.1 |
ATP2A2 | 12q24.11 |
CD99L2 | Xq28 |
CLCN6 | 1p36.22 |
CYFIP1 | 15q11.2 |
CYFIP2 | 5q33.3 |
GNB1 | 1p36.33 |
GPT2 | 16q11.2 |
HUWE1 | Xp11.22 |
KMT2D | 12q13.12 |
MYO18A | 17q11.2 |
NOS3 | 7q36.1 |
RYR1 | 19q13.2 |
RYR2 | 1q43 |
RYR3 | 15q13.3-q14 |
TAF1 | Xq13.1 |
TECTA | 11q23.3 |
PURA | 5q31.3 |
ARX, aristaless related homeobox; ATP2A2, ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2; CALN1, calneuron 1; CD99L2, CD99molecule like 2; CDKL5, cyclin dependent kinase like 5; CLCN6, chloride voltage-gated channel 6; CYFIP1, cytoplasmic FMR1 interacting protein 1; CYFIP2, cytoplasmic FMR1 interacting protein; DCX, doublecortin; FOXG1: forkhead box G1; GNB1, G protein subunit beta 1; GPT2, glutamic--pyruvic transaminase 2; GRIN2A, glutamate ionotropic receptor NMDA type subunit 2; HUWE1, HECT,UBA,WWE domain containing 1; IARS2, isoleucyl-tRNAsynthetase 2, mitochondrial; KCNQ2, potassium voltage-gated channel subfamily Q member 2; KMT2D, lysine methyltransferase 2D; MAGI2, membrane associated guanylatekynase; MYO18A, myosin XVIIIA; NEDD4, neural precursor cell espressed, developmentally down regulated 4-2, E3 ubiquitin protein ligase; NOS3, nitric oxide synthase 3; NSD1, nuclear receptor binding SET domain; PAFAH1B1, platelet activating factor acetylhydrolase; PHACTR1, phosphatase and actin regulator 1; PURA, purine rich element binding protein A; RARS2, arginyl-tRNAsynthetase 2, mitochondrial; RYR1, ryanodine receptor 1; RYR2, ryanodine receptor 2; RYR3, ryanodine receptor 3; SLC1A4, solute carrier family 1 member 4; SPTAN: spectrin alpha, non-erythrocytic